Calcific Uremic Arteriolopathy (Calciphylaxis): Successful Treatment with Sodium Thiosulfate in Spite of Elevated Serum Phosphate

Abstract

Get full access to this article

View all access options for this article.

References

Rogers

Coates

. Calcific uraemic arteriolopathy: An update. Curr Opin Nephrol Hypertens 2008; 17:629–34.

Dauden

Onate

. Calciphylaxis. Dermatol Clin 2008;26:557–68, ix.

Arseculeratne

Evans

Morley

. Calciphylaxis—a topical overview. J Eur Acad Dermatol Venereol 2006;20:493–502.

Angelis

Wong

Myers

Wong

. Calciphylaxis in patients on hemodialysis: A prevalence study. Surgery 1997;122:1083–9.

Wong

Laumann

Martinez

. Calciphylaxis and antiphospholipid antibody syndrome. J Am Acad Dermatol 2000;42:849.

Riegert-Johnson

Kaur

Pfeifer

. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K. Mayo Clin Proc 2001;76:749–52.

Raper

Ibels

. Osteosclerotic myeloma complicated by diffuse arteritis, vascular calcification and extensive cutaneous necrosis. Nephron 1985;39:389–92.

Ozbalkan

Calguneri

Onat

Ozturk

. Development of calciphylaxis after long-term steroid and methotrexate use in a patient with rheumatoid arthritis. Intern Med 2005;44:1178–81.

Nigwekar

Wolf

Sterns

Hix

. Calciphylaxis from nonuremic causes: A systematic review. Clin J Am Soc Nephrol 2008;3:1139–43.

10.

Mastruserio

Nguyen

Nielsen

. Calciphylaxis associated with metastatic breast carcinoma. J Am Acad Dermatol 1999;41:295–8.

11.

Kutlu

Aydin

Aslan

. Malignant melanoma of the soft parts showing calciphylaxis. Pediatr Hematol Oncol 2003;20:141–6.

12.

Korkmaz

Dundar

Zubaroglu

. Calciphylaxis in a patient with rheumatoid arthritis without renal failure and hyperparathyroidism: The possible role of long-term steroid use and protein S deficiency. Clin Rheumatol 2002;21:66–9.

13.

Goff

Grimwood

. A case of calciphylaxis and chronic myelomonocytic leukemia. Cutis 2005;75:325–8.

14.

R I

Filotico

Cea

. Calciphylaxis in a patient with POEMS syndrome without renal failure and/or hyperparathyroidism. A case report. Ann Ital Med Int 2004;19:283–7.

15.

Cockerell

Dolan

. Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodeficiency syndrome and renal disease. J Am Acad Dermatol 1992;26:559–62.

16.

Bosler

Amin

Gulli

Malhotra

. Unusual case of calciphylaxis associated with metastatic breast carcinoma. Am J Dermatopathol 2007;29:400–3.

17.

Bamberger

Emmerich

Fiessinger

. Calciphylaxis in patients with human immunodeficiency virus infection and renal disease. J Am Acad Dermatol 1993;28:135–6.

18.

Munavalli

Reisenauer

Moses

. Weight loss-induced calciphylaxis: Potential role of matrix metalloproteinases. J Dermatol 2003;30:915–9.

19.

Barri

Graves

Knochel

. Calciphylaxis in a patient with Crohn's disease in the absence of end-stage renal disease. Am J Kidney Dis 1997;29:773–6.

20.

Goyal

Huhn

Provost

. Calciphylaxis in a patient without renal failure or elevated parathyroid hormone: Possible aetiological role of chemotherapy. Br J Dermatol 2000;143:1087–90.

21.

Ferreres

Marcoval

Bordas

. Calciphylaxis associated with alcoholic cirrhosis. J Eur Acad Dermatol Venereol 2006;20:599–601.

22.

Goli

Shah

. Calciphylaxis: A rare association with alcoholic cirrhosis. Are deficiencies in protein C and S the cause?. South Med J 2005;98:736–9.

23.

Lim

Batta

Tan

. Calciphylaxis in a patient with alcoholic liver disease in the absence of renal failure. Clin Exp Dermatol 2003;28:34–6.

24.

Ahmed

O'Neill

Hood

. Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 2001;37:1267–76.

25.

Bleyer

Choi

Igwemezie

. A case control study of proximal calciphylaxis. Am J Kidney Dis 1998;32:376–83.

26.

Mazhar

Johnson

Gillen

. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 2001;60:324–32.

27.

Weenig

Sewell

Davis

. Calciphylaxis: Natural history, risk factor analysis, and outcome. J Am Acad Dermatol 2007;56:569–79.

28.

Fine

Zacharias

. Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int 2002;61:2210–7.

29.

Kriskovich

Holman

Haller

. Calciphylaxis: Is there a role for parathyroidectomy? Laryngoscope 2000;110:603–7.

30.

Galimberti

Farias

Parra

. Cutaneous necrosis by calcific uremic arteriolopathy. Int J Dermatol 2005;44:101–6.

31.

Weenig

. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol 2008;58:458–71.

32.

Wilmer

Magro

. Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002;15:172–86.

33.

Bleibel

Hazar

Herman

. A case report comparing various radiological tests in the diagnosis of calcific uremic arteriolopathy. Am J Kidney Dis 2006;48:659–61.

34.

Lazorik

Friedman

Leyden

. Xeroradiographic observations in four patients with chronic renal disease and cutaneous gangrene. Arch Dermatol 1981;117:325–8.

35.

Norris

Vaysman

Line

. Bone scintigraphy of calciphylaxis: A syndrome of vascular calcification and skin necrosis. Clin Nucl Med 2005;30:725–7.

36.

Hayden

Goldsmith

Sowers

Khanna

. Calciphylaxis: Calcific uremic arteriolopathy and the emerging role of sodium thiosulfate. Int Urol Nephrol 2008;40:443–51.

37.

Martin

. Mysterious calciphylaxis: Wounds with eschar—to debride or not to debride? Ostomy Wound Manage 2004;50:64–70.

38.

Hafner

Keusch

Wahl

. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): A complication of chronic renal failure and benefit from parathyroidectomy. J Am Acad Dermatol 1995;33:954–62.

39.

Hafner

Keusch

Wahl

Burg

. Calciphylaxis: A syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa 1998;27:137–43.

40.

Milas

Weber

. Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism. Surgery 2004;136:1252–60.

41.

Budisavljevic

Cheek

Ploth

. Calciphylaxis in chronic renal failure. J Am Soc Nephrol 1996;7:978–82.

42.

Girotto

Harmon

Ratner

. Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery 2001;130:645–50.

43.

Younis

Sells

Desmond

. Painful cutaneous lesions, renal failure and urgent parathyroidectomy. J Nephrol 2002;15:324–9.

44.

Duffy

Schurr

Warner

Chen

. Long-term outcomes in patients with calciphylaxis from hyperparathyroidism. Ann Surg Oncol 2006;13:96–102.

45.

Couto

Chen

Blank

Drezner

. Calciphylaxis in the absence of end-stage renal disease. Endocr Pract 2006;12:406–10.

46.

Arch-Ferrer

Beenken

Rue

. Therapy for calciphylaxis: An outcome analysis. Surgery 2003;134:941–4.

47.

Basile

Montanaro

Masi

. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: A case series. J Nephrol 2002;15:676–80.

48.

Basile

. Hyperbaric oxygen therapy in the treatment of calciphylaxis? Yes, more than hope. Kidney Int 2002;62:2300.

49.

Podymow

Wherrett

Burns

. Hyperbaric oxygen in the treatment of calciphylaxis: A case series. Nephrol Dial Transplant 2001;16:2176–80.

50.

Raymond

Wazny

. Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. Am J Health Syst Pharm 2008;65:1419–29.

51.

Monney

Nguyen

Perroud

Descombes

. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant 2004;19:2130–2.

52.

Shiraishi

Kitamura

Miyoshi

. Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. Am J Kidney Dis 2006;48:151–4.

53.

Musso

Enz

Guelman

. Non-ulcerating calcific uremic arteriolopathy skin lesion treated successfully with intravenous ibandronate. Perit Dial Int 2006;26:717–8.

54.

Hanafusa

Yamaguchi

Tani

. Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates. J Am Acad Dermatol 2007;57:1021–5.

55.

da Costa

Gomes

. Pamidronate as a treatment option in calciphylaxis. J Eur Acad Dermatol Venereol 2008;22:1128–30.

56.

Robinson

Augustine

Korman

. Cinacalcet for the treatment of calciphylaxis. Arch Dermatol 2007;143:152–4.

57.

Sharma

Burkitt-Wright

Rustom

. Cinacalcet as an adjunct in the successful treatment of calciphylaxis. Br J Dermatol 2006;155:1295–7.

58.

Velasco

MacGregor

Innes

MacKay

. Successful treatment of calciphylaxis with cinacalcet—an alternative to parathyroidectomy? Nephrol Dial Transplant 2006;21:1999–2004.

59.

Mohammed

Sekar

Bubtana

. Proximal calciphylaxis treated with calcimimetic ‘cinacalcet.’ Nephrol Dial Transplant 2008;23:387–9.

60.

Pallure

Comte

Leray-Mouragues

Dereure

. Cinacalcet as first-line treatment for calciphylaxis. Acta Derm Venereol 2008;88:62–3.

61.

Cicone

Petronis

Embert

Spector

. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 2004;43:1104–8.

62.

Guerra

Shah

Ross

. Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: Case report. Nephrol Dial Transplant 2005;20:1260–2.

63.

Brucculeri

Cheigh

Bauer

Serur

. Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial 2005;18:431–4.

64.

Araya

Fennell

Neiberger

Dharnidharka

. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol 2006;1:1161–6.

65.

Hayden

Tyagi

Kolb

. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: The emerging role of sodium thiosulfate. Cardiovasc Diabetol 2005;4:4.

66.

Meissner

Bauer

Beier

. Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis. Dermatology 2006;212:373–6.

67.

Tokashiki

Ishida

Kouchi

. Successful management of critical limb ischemia with intravenous sodium thiosulfate in a chronic hemodialysis patient. Clin Nephrol 2006;66:140–3.

68.

Baker

Fitzgibbons

Buescher

. Calciphylaxis responding to sodium thiosulfate therapy. Arch Dermatol 2007;143:269–70.

69.

Ackermann

Levy

Daugas

. Sodium thiosulfate as first-line treatment for calciphylaxis. Arch Dermatol 2007;143:1336–7.

70.

Subramaniam

Wallace

Sinniah

Saker

. Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate. Australas J Dermatol 2008;49:30–4.

71.

Mataic

Bastani

. Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis. Ren Fail 2006;28:361–3.

72.

Kadiyala

Roer

Perazella

. Nephrogenic systemic fibrosis associated with gadoversetamide exposure: Treatment with sodium thiosulfate. Am J Kidney Dis 2009;53:133–7.

73.

Yerram

Saab

Karuparthi

. Nephrogenic systemic fibrosis: A mysterious disease in patients with renal failure—role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol 2007;2:258–63.

74.

Linfert

Schell

Fine

. Treatment of nephrogenic systemic fibrosis: Limited options but hope for the future. Semin Dial 2008;21:155–9.